NUTRA PHARMA CORP

2022 Q4 Form 10-Q Financial Statement

#000149315222033171 Filed on November 21, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3 2021 Q4

Balance Sheet

Concept 2022 Q4 2022 Q3 2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $0.00 $90.91K
YoY Change -100.0%
Cash & Equivalents $90.91K
Short-Term Investments
Other Short-Term Assets $117.7K $86.15K
YoY Change -38.71% 761.5%
Inventory $49.35K $31.29K
Prepaid Expenses $117.7K $86.15K
Receivables $21.58K $46.00K
Other Receivables $3.000K $6.000K
Total Short-Term Assets $462.5K $533.8K
YoY Change -19.17% 864.46%
LONG-TERM ASSETS
Property, Plant & Equipment $85.61K $44.70K
YoY Change -44.93% -71.84%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $99.18K $107.7K
YoY Change -7.89% 22.81%
Total Long-Term Assets $228.2K $246.2K
YoY Change -13.28% -0.1%
TOTAL ASSETS
Total Short-Term Assets $462.5K $533.8K
Total Long-Term Assets $228.2K $246.2K
Total Assets $690.7K $780.0K
YoY Change -17.31% 158.47%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $712.8K $672.4K
YoY Change 16.47% 12.17%
Accrued Expenses $963.5K $851.5K
YoY Change -62.92% -65.56%
Deferred Revenue $111.0K
YoY Change
Short-Term Debt $61.44K $199.7K
YoY Change -66.11% -0.55%
Long-Term Debt Due $7.863M $7.600M
YoY Change 1.11% 63.71%
Total Short-Term Liabilities $16.15M $21.14M
YoY Change -32.08% 84.11%
LONG-TERM LIABILITIES
Long-Term Debt $151.7K $517.2K
YoY Change -77.03% 104.78%
Other Long-Term Liabilities $0.00
YoY Change -100.0%
Total Long-Term Liabilities $151.7K $517.2K
YoY Change -77.71% 65.23%
TOTAL LIABILITIES
Total Short-Term Liabilities $16.15M $21.14M
Total Long-Term Liabilities $151.7K $517.2K
Total Liabilities $16.30M $21.66M
YoY Change -33.35% 83.61%
SHAREHOLDERS EQUITY
Retained Earnings -$76.78M -$81.73M
YoY Change
Common Stock $61.16M $60.84M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$15.61M -$20.88M
YoY Change
Total Liabilities & Shareholders Equity $690.7K $780.0K
YoY Change -17.31% 158.47%

Cashflow Statement

Concept 2022 Q4 2022 Q3 2021 Q4

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2022Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2021Q3 us-gaap Revenue From Related Parties
RevenueFromRelatedParties
usd
us-gaap Revenue From Related Parties
RevenueFromRelatedParties
usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
usd
CY2021Q3 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
usd
CY2022Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
usd
dei Entity Central Index Key
EntityCentralIndexKey
0001119643
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022Q3 us-gaap Cash
Cash
usd
CY2021Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
usd
us-gaap Proceeds From Sale Of Notes Receivable
ProceedsFromSaleOfNotesReceivable
usd
us-gaap Proceeds From Issuance Of Other Long Term Debt
ProceedsFromIssuanceOfOtherLongTermDebt
usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
NPHC Warrants Issued With Debtdebt Discount
WarrantsIssuedWithDebtdebtDiscount
usd
NPHC Increase Of Rightofuse Asset Due To Lease Renewal
IncreaseOfRightofuseAssetDueToLeaseRenewal
usd
NPHC Increase Of Operating Lease Liabilities Due To Lease Renewa
IncreaseOfOperatingLeaseLiabilitiesDueToLeaseRenewa
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
NPHC Change In Fair Value Of Convertible Notes
ChangeInFairValueOfConvertibleNotes
usd
us-gaap Interest On Convertible Debt Net Of Tax
InterestOnConvertibleDebtNetOfTax
usd
us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
shares
CY2022Q3 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
shares
CY2021Q3 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
shares
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
shares
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
shares
CY2021Q4 us-gaap Advances Fair Value Disclosure
AdvancesFairValueDisclosure
usd
CY2022Q3 us-gaap Deferred Compensation Equity
DeferredCompensationEquity
usd
us-gaap Short Term Lease Cost
ShortTermLeaseCost
usd
CY2021 us-gaap Short Term Lease Cost
ShortTermLeaseCost
usd
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
usd
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
usd
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
usd
CY2021Q3 NPHC Net Sales To Related Party
NetSalesToRelatedParty
usd
NPHC Net Sales To Related Party
NetSalesToRelatedParty
usd
NPHC Bad Debt Expense Recovery Related Party
BadDebtExpenseRecoveryRelatedParty
usd
CY2021Q3 NPHC Rental Income From Related Party
RentalIncomeFromRelatedParty
usd
NPHC Rental Income From Related Party
RentalIncomeFromRelatedParty
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-32141
dei Entity Registrant Name
EntityRegistrantName
NUTRA PHARMA CORP
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
CA
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
91-2021600
dei Entity Address Address Line1
EntityAddressAddressLine1
1537 NW 65th Avenue
dei Entity Address City Or Town
EntityAddressCityOrTown
Plantation
dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
33313
dei City Area Code
CityAreaCode
954
dei Local Phone Number
LocalPhoneNumber
509–0911
dei Entity Current Reporting Status
EntityCurrentReportingStatus
No
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
7596852214 shares
CY2021Q4 us-gaap Cash
Cash
90910 usd
CY2022Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
21580 usd
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
45998 usd
CY2022Q3 us-gaap Inventory Net
InventoryNet
49346 usd
CY2021Q4 us-gaap Inventory Net
InventoryNet
31289 usd
CY2022Q3 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
3000 usd
CY2021Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
6000 usd
CY2022Q3 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
270896 usd
CY2021Q4 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
273480 usd
CY2022Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
117650 usd
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
86150 usd
CY2022Q3 us-gaap Assets Current
AssetsCurrent
462472 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
533827 usd
CY2022Q3 us-gaap Inventory Noncurrent
InventoryNoncurrent
90380 usd
CY2021Q4 us-gaap Inventory Noncurrent
InventoryNoncurrent
98880 usd
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
85606 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
44701 usd
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
43397 usd
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
93811 usd
CY2022Q3 us-gaap Security Deposit
SecurityDeposit
8803 usd
CY2021Q4 us-gaap Security Deposit
SecurityDeposit
8803 usd
CY2022Q3 us-gaap Assets
Assets
690658 usd
CY2021Q4 us-gaap Assets
Assets
780022 usd
CY2022Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
712757 usd
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
672372 usd
CY2022Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
963526 usd
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
851470 usd
CY2022Q3 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
1173693 usd
CY2021Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
1053693 usd
CY2022Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
111011 usd
CY2022Q3 us-gaap Interest Payable Current
InterestPayableCurrent
145508 usd
CY2021Q4 us-gaap Interest Payable Current
InterestPayableCurrent
147768 usd
CY2022Q3 us-gaap Due To Officers Or Stockholders Current
DueToOfficersOrStockholdersCurrent
61439 usd
CY2021Q4 us-gaap Due To Officers Or Stockholders Current
DueToOfficersOrStockholdersCurrent
199726 usd
CY2022Q3 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
5097169 usd
CY2021Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
10537344 usd
CY2022Q3 us-gaap Other Long Term Debt Current
OtherLongTermDebtCurrent
7860452 usd
CY2021Q4 us-gaap Other Long Term Debt Current
OtherLongTermDebtCurrent
7598325 usd
CY2022Q3 us-gaap Notes Payable Current
NotesPayableCurrent
2930 usd
CY2021Q4 us-gaap Notes Payable Current
NotesPayableCurrent
2121 usd
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
20003 usd
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
77673 usd
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
16148488 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
21140492 usd
CY2022Q3 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
4707 usd
CY2021Q4 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
369401 usd
CY2022Q3 us-gaap Long Term Notes Payable
LongTermNotesPayable
146970 usd
CY2021Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
147779 usd
CY2022Q3 us-gaap Liabilities
Liabilities
16300165 usd
CY2021Q4 us-gaap Liabilities
Liabilities
21657672 usd
CY2022Q3 us-gaap Preferred Stock Value
PreferredStockValue
12000 usd
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
12000 usd
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
12000000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
12000000000 shares
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7596852214 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7596852214 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7330985964 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7330985964 shares
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
7596852 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
7330986 usd
CY2022Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
53565739 usd
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
53508353 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-76784098 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-81728989 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-15609507 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-20877650 usd
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
690658 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
780022 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
24624 usd
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
19266 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
66814 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
71748 usd
CY2022Q3 us-gaap Revenue From Related Parties
RevenueFromRelatedParties
84580 usd
us-gaap Revenue From Related Parties
RevenueFromRelatedParties
154966 usd
CY2022Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
41051 usd
CY2021Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
9644 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
116254 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
24284 usd
CY2022Q3 us-gaap Gross Profit
GrossProfit
68153 usd
CY2021Q3 us-gaap Gross Profit
GrossProfit
9622 usd
us-gaap Gross Profit
GrossProfit
105526 usd
us-gaap Gross Profit
GrossProfit
47464 usd
CY2022Q3 us-gaap Share Based Compensation
ShareBasedCompensation
0 usd
CY2021Q3 us-gaap Share Based Compensation
ShareBasedCompensation
64750 usd
us-gaap Share Based Compensation
ShareBasedCompensation
20500 usd
us-gaap Share Based Compensation
ShareBasedCompensation
66195 usd
CY2022Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
326473 usd
CY2021Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
556932 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
991557 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1501689 usd
CY2022Q3 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-21799 usd
CY2021Q3 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-35000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
38000 usd
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
304674 usd
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
521932 usd
us-gaap Operating Expenses
OperatingExpenses
991557 usd
us-gaap Operating Expenses
OperatingExpenses
1539689 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-236521 usd
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-512310 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-886031 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-1492225 usd
CY2022Q3 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
4210 usd
CY2021Q3 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
4750 usd
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
16215 usd
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
6465 usd
CY2022Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
195424 usd
CY2021Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
131482 usd
us-gaap Interest Expense Debt
InterestExpenseDebt
580075 usd
us-gaap Interest Expense Debt
InterestExpenseDebt
346792 usd
CY2022Q3 us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
4272 usd
CY2021Q3 us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
4504 usd
us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
12740 usd
us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
13881 usd
CY2022Q3 NPHC Change In Fair Value Of Convertible Notes And Derivatives
ChangeInFairValueOfConvertibleNotesAndDerivatives
1019736 usd
CY2021Q3 NPHC Change In Fair Value Of Convertible Notes And Derivatives
ChangeInFairValueOfConvertibleNotesAndDerivatives
16133270 usd
NPHC Change In Fair Value Of Convertible Notes And Derivatives
ChangeInFairValueOfConvertibleNotesAndDerivatives
6569581 usd
NPHC Change In Fair Value Of Convertible Notes And Derivatives
ChangeInFairValueOfConvertibleNotesAndDerivatives
-12824783 usd
CY2022Q3 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
10500 usd
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
10500 usd
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
107500 usd
CY2021Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-56339 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-151559 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-485836 usd
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
813750 usd
CY2021Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
15945695 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
5830922 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-13772327 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
577229 usd
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
15433385 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
4944891 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-15264552 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
577229 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
15433385 usd
us-gaap Net Income Loss
NetIncomeLoss
4944891 usd
us-gaap Net Income Loss
NetIncomeLoss
-15264552 usd
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7592286997 shares
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7289196290 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7471152031 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7201163176 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15597613916 shares
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12670053386 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15104777470 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7201163176 shares
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-16197236 usd
CY2022Q3 NPHC Stock Issued During Period Value Debt Modification And Penalty
StockIssuedDuringPeriodValueDebtModificationAndPenalty
10500 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
577229 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-15609507 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-39244098 usd
CY2021Q3 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
117000 usd
CY2021Q3 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
73032 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
15433385 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-23620681 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-20877650 usd
NPHC Stock Issued During Period Value Debt Modification And Penalty
StockIssuedDuringPeriodValueDebtModificationAndPenalty
10500 usd
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
36000 usd
us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
276752 usd
us-gaap Net Income Loss
NetIncomeLoss
4944891 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-15609507 usd
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-11493815 usd
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-11493815 usd
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
150000 usd
NPHC Stock Issued During Period Value Debt Modification And Penalty
StockIssuedDuringPeriodValueDebtModificationAndPenalty
107500 usd
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
2344399 usd
us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
535787 usd
us-gaap Net Income Loss
NetIncomeLoss
-15264552 usd
us-gaap Net Income Loss
NetIncomeLoss
-15264552 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-23620681 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-23620681 usd
us-gaap Net Income Loss
NetIncomeLoss
4944891 usd
us-gaap Net Income Loss
NetIncomeLoss
-15264552 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
38000 usd
NPHC Accrued Interest Expense For Amount Due To Officer
AccruedInterestExpenseForAmountDueToOfficer
3512 usd
NPHC Accrued Interest Expense For Amount Due To Officer
AccruedInterestExpenseForAmountDueToOfficer
5788 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-151559 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-485836 usd
us-gaap Depreciation
Depreciation
17088 usd
us-gaap Depreciation
Depreciation
6178 usd
us-gaap Share Based Compensation
ShareBasedCompensation
20500 usd
us-gaap Share Based Compensation
ShareBasedCompensation
66195 usd
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
10500 usd
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
107500 usd
NPHC Amortization Of Convertible Notes Receivable Discount
AmortizationOfConvertibleNotesReceivableDiscount
16215 usd
NPHC Amortization Of Convertible Notes Receivable Discount
AmortizationOfConvertibleNotesReceivableDiscount
6465 usd
NPHC Change In Fair Value Of Convertible Notes And Derivatives
ChangeInFairValueOfConvertibleNotesAndDerivatives
6569581 usd
NPHC Change In Fair Value Of Convertible Notes And Derivatives
ChangeInFairValueOfConvertibleNotesAndDerivatives
-12824783 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
404549 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
232117 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
50414 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
35995 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-24418 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
4359 usd
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
12000 usd
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
9000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
9557 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
47737 usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
120250 usd
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
710000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
52000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
98150 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
40385 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
12516 usd
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
112056 usd
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
56973 usd
us-gaap Increase Decrease In Accrued Salaries
IncreaseDecreaseInAccruedSalaries
120000 usd
us-gaap Increase Decrease In Accrued Salaries
IncreaseDecreaseInAccruedSalaries
125500 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
111011 usd
NPHC Increase In Accrued Interest To Related Parties
IncreaseInAccruedInterestToRelatedParties
-2260 usd
NPHC Increase In Accrued Interest To Related Parties
IncreaseInAccruedInterestToRelatedParties
-26120 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-57670 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-51787 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-708400 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1510789 usd
us-gaap Payments To Acquire Notes Receivable
PaymentsToAcquireNotesReceivable
16451 usd
us-gaap Payments To Acquire Notes Receivable
PaymentsToAcquireNotesReceivable
242500 usd
us-gaap Proceeds From Sale Of Notes Receivable
ProceedsFromSaleOfNotesReceivable
50250 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
57993 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
34768 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-24194 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-277268 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
62201 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
56900 usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
204000 usd
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
1976560 usd
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
60994 usd
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
65028 usd
us-gaap Proceeds From Issuance Of Other Long Term Debt
ProceedsFromIssuanceOfOtherLongTermDebt
251340 usd
us-gaap Repayments Of Other Long Term Debt
RepaymentsOfOtherLongTermDebt
116863 usd
us-gaap Repayments Of Other Long Term Debt
RepaymentsOfOtherLongTermDebt
15375 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
641684 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1832807 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-90910 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
44750 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
90910 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
44750 usd
us-gaap Interest Paid Net
InterestPaidNet
84460 usd
us-gaap Interest Paid Net
InterestPaidNet
41951 usd
us-gaap Notes Issued1
NotesIssued1
287252 usd
us-gaap Notes Issued1
NotesIssued1
535787 usd
us-gaap Stock Issued1
StockIssued1
36000 usd
us-gaap Stock Issued1
StockIssued1
2344399 usd
NPHC Warrants Issued With Debtdebt Discount
WarrantsIssuedWithDebtdebtDiscount
100000 usd
NPHC Increase Of Rightofuse Asset Due To Lease Renewal
IncreaseOfRightofuseAssetDueToLeaseRenewal
4102 usd
NPHC Increase Of Operating Lease Liabilities Due To Lease Renewa
IncreaseOfOperatingLeaseLiabilitiesDueToLeaseRenewa
4102 usd
NPHC Reclassification Of Other Receivable To Convertible Note Receivable
ReclassificationOfOtherReceivableToConvertibleNoteReceivable
15000 usd
NPHC Reclassification Of Other Receivable To Convertible Note Receivable
ReclassificationOfOtherReceivableToConvertibleNoteReceivable
6000 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-76784098 usd
CY2022Q3 NPHC Working Capital
WorkingCapital
-15686016 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-15609507 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84D_eus-gaap--UseOfEstimates_zaZE5Xyl4Svd" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86B_zsmRfklKe16l">Use of Estimates</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying Unaudited Condensed Consolidated Financial Statements are prepared in accordance with accounting principles generally accepted in the United States of America which require management to make estimates and assumptions. These estimates and assumptions affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expense. Significant estimates include our ability to continue as going concern, the recoverability of inventories and long-lived assets, the recoverability of amounts due from officer, the valuation of stock-based compensation and certain debt and derivative liabilities, recognition of loss contingencies and deferred tax valuation allowances. Actual results could differ from those estimates. Changes in facts and circumstances may result in revised estimates, which would be recorded in the period in which they become known.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
NPHC Accounting For Shipping And Handling Costs Policy Tex Block
AccountingForShippingAndHandlingCostsPolicyTexBlock
<p id="xdx_841_ecustom--AccountingForShippingAndHandlingCostsPolicyTexBlock_zAaUsUoSuKPe" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_862_zT6qTHoBvh0h">Accounting for Shipping and Handling Costs</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We account for shipping and handling as fulfillment activities and record amounts billed to customers as revenue and the related shipping and handling costs as cost of sales.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0 usd
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0 usd
us-gaap Inventory Write Down
InventoryWriteDown
0 usd
CY2021 us-gaap Inventory Write Down
InventoryWriteDown
48000 usd
CY2022Q3 us-gaap Inventory Adjustments
InventoryAdjustments
294162 usd
CY2021Q4 us-gaap Inventory Adjustments
InventoryAdjustments
294162 usd
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_848_eus-gaap--ConcentrationRiskCreditRisk_zEVasVzEe897" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86A_zSgNSMfWf1C">Financial Instruments and Concentration of Credit Risk</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our financial instruments include cash, accounts receivable, accounts payable, accrued expenses, loans payable, due to officers and derivative financial instruments. Other than certain warrant and convertible instruments (derivative financial instruments) and liabilities to related parties (for which it was impracticable to estimate fair value due to uncertainty as to when they will be satisfied and a lack of similar type transactions in the marketplace), we believe the carrying values of our financial instruments approximate their fair values because they are short term in nature or payable on demand. Our derivative financial instruments are carried at fair value.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balances in various cash accounts may at times exceed federally insured limits. We have not experienced any losses in such accounts. We do not hold or issue financial instruments for trading purposes. In addition, for the three months ended September 30, 2022, one customer accounted for <span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220701__20220930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneCustomerMember_z4PYTJiKNlyb">77</span>% of the total revenues. For the three months ended September 30, 2021, there was no customer accounted for more than <span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210701__20210930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneCustomerMember_zzbUaIWwWPbj">10</span>% of the total revenues. For the nine months ended September 30, 2022, one customer accounted for <span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20220930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneCustomerMember_zlpnI6XhF9cl">70</span>% of the total revenues. For the nine months ended September 30, 2021, one customer accounted for <span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20210930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneCustomerMember_zdNmRNOGFIt3" title="Concentration risk, percentage">25</span>% of the total revenues. As of September 30, 2022 and December 31, 2021, <span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20220930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneCustomerMember_zi5JyfeQPrQe"><span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneCustomerMember_zxnwAKrK51Rj">100</span></span>% of the accounts receivable balance are reserves due from one and two payment processors, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p>
us-gaap Derivatives Reporting Of Derivative Activity
DerivativesReportingOfDerivativeActivity
<p id="xdx_843_eus-gaap--DerivativesReportingOfDerivativeActivity_z9LZETEdSXq5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_861_zawI91U4ws6k">Derivative Financial Instruments</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management evaluates all of its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported as charges or credits to other income. For option-based simple derivative financial instruments, the Company uses the Black-Scholes option-pricing model to value the derivative instruments at inception and subsequent valuation dates. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument could be required within 12 months of the balance sheet date.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We do not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
577229 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
15433385 usd
us-gaap Net Income Loss
NetIncomeLoss
4944891 usd
us-gaap Net Income Loss
NetIncomeLoss
-15264552 usd
CY2022Q3 NPHC Change In Fair Value Of Convertible Notes
ChangeInFairValueOfConvertibleNotes
-730917 usd
CY2021Q3 NPHC Change In Fair Value Of Convertible Notes
ChangeInFairValueOfConvertibleNotes
-2595948 usd
NPHC Change In Fair Value Of Convertible Notes
ChangeInFairValueOfConvertibleNotes
-805027 usd
CY2022Q3 us-gaap Interest On Convertible Debt Net Of Tax
InterestOnConvertibleDebtNetOfTax
61313 usd
CY2021Q3 us-gaap Interest On Convertible Debt Net Of Tax
InterestOnConvertibleDebtNetOfTax
91454 usd
us-gaap Interest On Convertible Debt Net Of Tax
InterestOnConvertibleDebtNetOfTax
213995 usd
CY2022Q3 us-gaap Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
-92375 usd
CY2021Q3 us-gaap Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
12928891 usd
us-gaap Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
4353859 usd
us-gaap Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
-15264552 usd
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7592286997 shares
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7289196290 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7471152031 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7201163176 shares
CY2022Q3 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
8005326919 shares
CY2021Q3 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
5380857096 shares
us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
7633625439 shares
CY2022Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
15597613916 shares
CY2021Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
12670053386 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
15104777470 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
7201163176 shares
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2022Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
447014285 shares
CY2021Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
108175000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
447014285 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5743858645 shares
CY2022Q3 NPHC Warrant Liability Fair Value Disclosures
WarrantLiabilityFairValueDisclosures
200103 usd
CY2022Q3 us-gaap Derivative Fair Value Of Derivative Net
DerivativeFairValueOfDerivativeNet
4897066 usd
CY2022Q3 us-gaap Convertible Debt Fair Value Disclosures
ConvertibleDebtFairValueDisclosures
1745305 usd
CY2021Q4 NPHC Warrant Liability Fair Value Disclosures
WarrantLiabilityFairValueDisclosures
710585 usd
CY2021Q4 us-gaap Derivative Fair Value Of Derivative Net
DerivativeFairValueOfDerivativeNet
9826759 usd
CY2021Q4 us-gaap Convertible Debt Fair Value Disclosures
ConvertibleDebtFairValueDisclosures
2855709 usd
CY2021Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
710585 usd
CY2020Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
189543 usd
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases Sales Issuances Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements
100000 usd
CY2021 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases Sales Issuances Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements
590885 usd
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
610482 usd
CY2021 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
69843 usd
CY2022Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
200103 usd
CY2021Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
710585 usd
CY2022Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
131005 usd
CY2021Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
126349 usd
CY2022Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
8721 usd
CY2021Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
3820 usd
CY2022Q3 us-gaap Inventory Gross
InventoryGross
139726 usd
CY2021Q4 us-gaap Inventory Gross
InventoryGross
130169 usd
CY2022Q3 us-gaap Inventory Noncurrent
InventoryNoncurrent
90380 usd
CY2021Q4 us-gaap Inventory Noncurrent
InventoryNoncurrent
98880 usd
CY2022Q3 us-gaap Inventory Net
InventoryNet
49346 usd
CY2021Q4 us-gaap Inventory Net
InventoryNet
31289 usd
CY2022Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
324879 usd
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
266886 usd
CY2022Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
239273 usd
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
222185 usd
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
85606 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
44701 usd
us-gaap Depreciation
Depreciation
17088 usd
us-gaap Depreciation
Depreciation
6178 usd
CY2022Q3 us-gaap Depreciation
Depreciation
5898 usd
CY2021Q3 us-gaap Depreciation
Depreciation
2793 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
38000 usd
CY2022Q3 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-21799 usd
CY2021Q3 NPHC Provision For Doubtful Accounts Bad Debt Recovery
ProvisionForDoubtfulAccountsBadDebtRecovery
-35000 usd
CY2021 NPHC Accrued Interest Expense For Amount Due To Officer
AccruedInterestExpenseForAmountDueToOfficer
7520 usd
CY2022Q3 us-gaap Notes Payable
NotesPayable
1285287 usd
CY2021Q4 us-gaap Notes Payable
NotesPayable
1135257 usd
CY2022Q3 NPHC Convertible Notes Payable Unrelated Third Parties
ConvertibleNotesPayableUnrelatedThirdParties
4609567 usd
CY2021Q4 NPHC Convertible Notes Payable Unrelated Third Parties
ConvertibleNotesPayableUnrelatedThirdParties
3751760 usd
CY2022Q3 NPHC Convertible Notes Payable At Fair Value
ConvertibleNotesPayableAtFairValue
1745305 usd
CY2021Q4 NPHC Convertible Notes Payable At Fair Value
ConvertibleNotesPayableAtFairValue
2855709 usd
CY2022Q3 NPHC Other Advances From Unrelated Third Party
OtherAdvancesFromUnrelatedThirdParty
225000 usd
CY2021Q4 NPHC Other Advances From Unrelated Third Party
OtherAdvancesFromUnrelatedThirdParty
225000 usd
CY2022Q3 NPHC Long Term Notes Payables
LongTermNotesPayables
149900 usd
CY2021Q4 NPHC Long Term Notes Payables
LongTermNotesPayables
149900 usd
CY2022Q3 us-gaap Other Notes Payable
OtherNotesPayable
8015059 usd
CY2021Q4 us-gaap Other Notes Payable
OtherNotesPayable
8117626 usd
CY2022Q3 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
4707 usd
CY2021Q4 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
369401 usd
CY2022Q3 NPHC Less Longterm Portion Sba Notes Payable
LessLongtermPortionSbaNotesPayable
146970 usd
CY2021Q4 NPHC Less Longterm Portion Sba Notes Payable
LessLongtermPortionSbaNotesPayable
146970 usd
CY2022Q3 us-gaap Debt Current
DebtCurrent
7863382 usd
CY2021Q4 us-gaap Debt Current
DebtCurrent
7600446 usd
CY2022Q3 us-gaap Notes Payable
NotesPayable
1285287 usd
CY2021Q4 us-gaap Notes Payable
NotesPayable
1135257 usd
CY2022Q3 NPHC Convertible Notes Payable Unrelated Third Parties
ConvertibleNotesPayableUnrelatedThirdParties
4609567 usd
CY2021Q4 NPHC Convertible Notes Payable Unrelated Third Parties
ConvertibleNotesPayableUnrelatedThirdParties
3751760 usd
CY2019Q4 NPHC Repayments Of Notes Payablerelated Party
RepaymentsOfNotesPayablerelatedParty
13500 usd
CY2022Q3 us-gaap Notes Payable
NotesPayable
166926 usd
CY2022Q3 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
16693 usd
CY2021Q3 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
16693 usd
CY2022Q3 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
3000 usd
CY2022Q3 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
17250 usd
CY2022Q3 us-gaap Debt Instrument Periodic Payment
DebtInstrumentPeriodicPayment
3000 usd
CY2022Q3 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
500000 shares
CY2022Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
500 usd
CY2022Q3 us-gaap Other Expenses
OtherExpenses
500 usd
CY2022Q3 us-gaap Convertible Debt Fair Value Disclosures
ConvertibleDebtFairValueDisclosures
1745305 usd
CY2021Q4 us-gaap Convertible Debt Fair Value Disclosures
ConvertibleDebtFairValueDisclosures
2855709 usd
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
8000000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
12000000000 shares
CY2022Q3 us-gaap Share Price
SharePrice
0.133
CY2020Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
92100000 shares
CY2020Q3 NPHC Month Of Expiration Of Warrants
MonthOfExpirationOfWarrants
August, 2022
CY2020Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
36300000 shares
CY2020Q4 NPHC Month Of Expiration Of Warrants
MonthOfExpirationOfWarrants
October, 2022
NPHC Weighted Average Number Of Shares Outstanding Warrants
WeightedAverageNumberOfSharesOutstandingWarrants
447014285 shares
NPHC Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Non Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableNonOptionsWeightedAverageRemainingContractualTerm2
P0Y3M18D
CY2022Q3 NPHC Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice
0.0019
CY2021 NPHC Weighted Average Number Of Shares Outstanding Warrants
WeightedAverageNumberOfSharesOutstandingWarrants
446703571 shares
CY2021 NPHC Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Non Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableNonOptionsWeightedAverageRemainingContractualTerm2
P0Y8M1D
CY2021Q4 NPHC Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice
0.0017
CY2022Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
161550 usd
CY2021Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
161550 usd
CY2022Q3 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
227912 usd
CY2021Q4 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
215543 usd
CY2022Q3 us-gaap Interest And Dividends Payable Current
InterestAndDividendsPayableCurrent
571151 usd
CY2021Q4 us-gaap Interest And Dividends Payable Current
InterestAndDividendsPayableCurrent
469040 usd
CY2022Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2913 usd
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
5337 usd
CY2022Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
963526 usd
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
43397 usd
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
93811 usd
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
20003 usd
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
77673 usd
CY2022Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
20003 usd
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
77673 usd
CY2022Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P0Y3M
CY2021Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y
CY2022Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.08 pure
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
851470 usd
CY2022Q3 us-gaap Advances On Inventory Purchases
AdvancesOnInventoryPurchases
339162 usd
CY2021Q4 us-gaap Advances On Inventory Purchases
AdvancesOnInventoryPurchases
294162 usd
CY2022Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
294162 usd
CY2021Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
294162 usd
CY2022Q3 us-gaap Advances Fair Value Disclosure
AdvancesFairValueDisclosure
45000 usd
CY2022Q3 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
72650 usd
CY2021Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
65650 usd
CY2021Q4 us-gaap Deferred Compensation Equity
DeferredCompensationEquity
20500 usd
CY2022Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
117650 usd
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
86150 usd
CY2022Q3 us-gaap Inventory Raw Materials And Supplies Net Of Reserves
InventoryRawMaterialsAndSuppliesNetOfReserves
0 usd
CY2021Q4 us-gaap Inventory Raw Materials And Supplies Net Of Reserves
InventoryRawMaterialsAndSuppliesNetOfReserves
48000 usd
CY2022Q3 NPHC Total Valuation Allowance For Prepaid
TotalValuationAllowanceForPrepaid
294162 usd
CY2021Q4 NPHC Total Valuation Allowance For Prepaid
TotalValuationAllowanceForPrepaid
294162 usd
CY2022Q3 us-gaap Proceeds From Sale Of Notes Receivable
ProceedsFromSaleOfNotesReceivable
50250 usd
CY2022Q3 NPHC Convertible Notes Receivable Current
ConvertibleNotesReceivableCurrent
270896 usd
CY2021Q4 NPHC Convertible Notes Receivable Current
ConvertibleNotesReceivableCurrent
273480 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
60297 usd
CY2021 us-gaap Operating Lease Cost
OperatingLeaseCost
80396 usd
us-gaap Lease Cost
LeaseCost
60297 usd
CY2021 us-gaap Lease Cost
LeaseCost
80396 usd
CY2021Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.08 pure
CY2022Q3 NPHC Operating Lease Liability Cash Paid For Measurement
OperatingLeaseLiabilityCashPaidForMeasurement
67553 usd
CY2021Q4 NPHC Operating Lease Liability Cash Paid For Measurement
OperatingLeaseLiabilityCashPaidForMeasurement
95846 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
20270 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
20270 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
267 usd
CY2022Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
20003 usd
CY2022Q3 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
0.18
CY2022Q3 us-gaap Accrued Liabilities For Commissions Expense And Taxes
AccruedLiabilitiesForCommissionsExpenseAndTaxes
142500 usd
CY2016Q4 us-gaap Deferred Compensation Arrangement With Individual Recorded Liability
DeferredCompensationArrangementWithIndividualRecordedLiability
31750 usd
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1000000 shares
CY2022Q3 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
19150 usd
CY2021Q4 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
19150 usd
CY2021 NPHC Share Based Compensation Shares Not Yet Issued
ShareBasedCompensationSharesNotYetIssued
1500000 shares
us-gaap Loss Contingency Allegations
LossContingencyAllegations
The violations alleged against the Company by the SEC include: (a) raising over $920,000 in at least two private placement offerings for which the Company failed to file required registration statements with the SEC; (b) issuing a series of materially false or misleading press releases; (c) making false statements in at least one Form 10-Q; and (d) failing to make required public filings with the SEC to disclose the Company’s issuance of millions of shares of stock. The lawsuit makes additional allegations against Mr. McManus and Mr. Deitsch, including that Mr. McManus acted as a broker without SEC registration and defrauded at least one investor by making false statements about the Company, that Mr. Deitsch engaged in manipulative trades of the Company’s stock by offering to pay more for shares he was purchasing than the amount the seller was willing to take, and that Mr. Deitsch failed to make required public filings with the SEC. The lawsuit seeks both injunctive and monetary relief.
CY2022Q2 us-gaap Payments For Rent
PaymentsForRent
5000 usd
CY2022Q3 us-gaap Payments For Rent
PaymentsForRent
10000 usd
us-gaap Payments For Rent
PaymentsForRent
10000 usd
CY2022Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
111011 usd
CY2022Q3 us-gaap Interest Payable Current
InterestPayableCurrent
145508 usd
CY2021Q4 us-gaap Interest Payable Current
InterestPayableCurrent
147768 usd
CY2022Q3 NPHC Net Sales To Related Party
NetSalesToRelatedParty
84580 usd
NPHC Net Sales To Related Party
NetSalesToRelatedParty
154966 usd
CY2022Q3 NPHC Bad Debt Expense Recovery Related Party
BadDebtExpenseRecoveryRelatedParty
-21799 usd
CY2021Q3 NPHC Bad Debt Expense Recovery Related Party
BadDebtExpenseRecoveryRelatedParty
-35000 usd
NPHC Bad Debt Expense Recovery Related Party
BadDebtExpenseRecoveryRelatedParty
38000 usd
CY2022Q3 NPHC Rental Income From Related Party
RentalIncomeFromRelatedParty
10000 usd
NPHC Rental Income From Related Party
RentalIncomeFromRelatedParty
10000 usd
CY2022Q3 us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
4272 usd
CY2021Q3 us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
4504 usd
us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
12740 usd
us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
13881 usd

Files In Submission

Name View Source Status
0001493152-22-033171-index-headers.html Edgar Link pending
0001493152-22-033171-index.html Edgar Link pending
0001493152-22-033171.txt Edgar Link pending
0001493152-22-033171-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex32-1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
nphc-20220930.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
nphc-20220930_def.xml Edgar Link unprocessable
nphc-20220930_cal.xml Edgar Link unprocessable
nphc-20220930_lab.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
nphc-20220930_pre.xml Edgar Link unprocessable